Author

Qing Leng

Institutions: Jilin University, Anshan Hospital

Observed institutions: Jilin University, Anshan Hospital, China Medical University

OpenAlex ID: A5083178617

Extranodal diffuse large B‐cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study

2025 · Si‐Yuan Chen, Peng‐Peng Xu, et al. · 癌症：英文版 · 21

Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure

2021 · Junxia Hu, Xin Wang, et al. · Frontiers in Oncology · 16

Safety and efficacy of flumatinib as later-line therapy in patients with chronic myeloid leukemia

2024 · Yunfan Yang, Yuntao Liu, et al. · Haematologica · 7

Promyelocyte-like blasts in B-lymphoblastic leukemia of a 67-year-old male patient

2019 · Yu Ma, Qing Leng, et al. · International Journal of Hematology · 1

Superior 12-month progression-free survival with frontline DVd versus VRd in patients with newly diagnosed multiple myeloma: a multicenter propensity score-matched analysis

2026 · Huinan Jiang, Qian Li, et al. · Journal of Translational Medicine

Additional file 1 of Superior 12-month progression-free survival with frontline DVd versus VRd in patients with newly diagnosed multiple myeloma: a multicenter propensity score-matched analysis

2026 · Huinan Jiang, Qian Li, et al. · Figshare

A mouse model of allergic conjunctivitis with mucosal immune-related gene and circRNA dysregulation

2026 · Hongyu Zhang, Hongyu Zhang, et al. · Frontiers in Immunology

Efficacy and safety of pegylated interferon alfa-2b in myeloproliferative neoplasms: A multicenter retrospective study of 210 patients

2025 · Qing Leng, Yueyue Zheng, et al. · Blood

Olverembatinib in accelerated-phase chronic myeloid leukemia: efficacy and safety evaluation

2025 · Mengyao Yuan, Li Zhou, et al. · Haematologica

Mitoxantrone Hydrochloride Liposome, Proteasome Inhibitors, Pomalidomide and Dexamethasone Regimen in Multiple Myeloma Patients with Extramedullary Plasmacytoma in China

2024 · Menghan Liu, Jigang Wang, et al. · Blood

Efficacy and Safety of Daratumumab Combined with Bortezomib and Dexamethasone Regimen in Newly-Diagnosed Multiple Myeloma Patients

2024 · Huinan Jiang, Xianming He, et al. · Blood

Olverembatinib-Therapy in Patients with Accelerated-Phase Chronic Myeloid Leukaemia: A Multi-Centre Retrospective Study from China

2024 · Mengyao Yuan, Li Zhou, et al. · Blood

Evaluating Effectiveness and Safety of Flumatinib for Chronic Phase Chronic Myeloid Leukemia in (CML-CP) without Optimal Response (Warning, Failure) to Imatinib or/and Dasatinib

2023 · Li Weiming, Yanli Zhang, et al. · Blood

Safety and Efficacy of Flumatinib in Patients with Chronic Myeloid Leukemia Resistant or Intolerant to Imatinib

2023 · Yuntao Liu, Yunfan Yang, et al. · Blood

Short-term efficacy and safety of rhTPO combined with traditional monotherapy regimen for the treatment of ITP: a Meta-analysis

2018 · Chaoqi Yan, Guo-Ping You, et al. · Guoji shuxue ji xueyexue zazhi

Works count: 15

Citation count: 45

H-index: 3

I10-index: 2